Stock Price
16.39
Daily Change
-0.11 -0.67%
Monthly
0.55%
Yearly
11.88%
Q1 Forecast
16.00



Peers Price Chg Day Year Date
Agrana Beteiligungs 11.75 0.25 2.17% 11.37% Feb/23
Austevoll Seafood 93.40 -2.50 -2.61% -12.30% Feb/23
British American Tobacco 4,597.00 28.00 0.61% 52.52% Feb/23
Beiersdorf 107.80 1.30 1.22% -16.47% Feb/23
Danone 72.04 -1.56 -2.12% 3.12% Feb/23
Givaudan 3,054.00 24.00 0.79% -23.75% Feb/23
Glanbia 16.39 -0.11 -0.67% 11.88% Feb/23
Henkel 83.58 0.92 1.11% -1.28% Feb/23
International Flavors Fragrances 82.23 0.84 1.03% 3.29% Feb/23
Imperial Brands 3,300.00 70.00 2.17% 20.31% Feb/23

Indexes Price Day Year Date
ISEQ 12932 -75.52 -0.58% 20.66% Feb/23
EU600 628 0 0% 13.26% Feb/24

Glanbia traded at 16.39 this Monday February 23rd, decreasing 0.11 or 0.67 percent since the previous trading session. Looking back, over the last four weeks, Glanbia lost 0.55 percent. Over the last 12 months, its price rose by 11.88 percent. Looking ahead, we forecast Glanbia to be priced at 16.00 by the end of this quarter and at 14.58 in one year, according to Trading Economics global macro models projections and analysts expectations.

Glanbia plc is a global nutrition company. The Company operates through two segments: Glanbia Performance Nutrition and Glanbia Nutritionals. The Company's Glanbia Performance Nutrition segment includes performance nutrition products. Its products are sold through a range of channels, including specialty retail, the Internet and gyms in a range of formats, including powders, bars and ready-to-drink beverages. The Company's Glanbia Nutritionals segment provides nutritional solutions. It manufactures and sells cheese, dairy and non-dairy nutritional ingredients and vitamin and mineral premixes targeting the market focus on health and nutrition.